Novartis AG
NVSEF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $11,939 | $9,145 | $6,955 | $24,018 |
| Dep. & Amort. | $6,069 | $8,277 | $7,181 | $6,113 |
| Deferred Tax | $1,701 | $551 | $1,416 | $2,119 |
| Stock-Based Comp. | $1,044 | $865 | $791 | $700 |
| Change in WC | -$706 | -$369 | -$1,003 | $241 |
| Other Non-Cash | -$2,428 | -$4,011 | -$1,136 | -$18,156 |
| Operating Cash Flow | $17,619 | $14,458 | $14,236 | $15,071 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,366 | -$2,938 | -$2,671 | -$2,971 |
| Net Acquisitions | -$3,921 | -$3,545 | -$903 | $20,102 |
| Inv. Purchases | -$3,547 | -$747 | -$34,816 | -$16,594 |
| Inv. Sales/Matur. | $3,701 | $11,596 | $39,490 | $2,740 |
| Other Inv. Act. | -$2,380 | $1,230 | $368 | $931 |
| Investing Cash Flow | -$7,513 | $5,596 | $1,468 | $4,208 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $4,390 | -$1,790 | -$2,399 | -$2,440 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$8,331 | -$8,719 | -$10,652 | -$3,057 |
| Dividends Paid | -$7,624 | -$7,255 | -$7,752 | -$7,384 |
| Other Fin. Act. | -$177 | $3,486 | -$5 | -$3,399 |
| Financing Cash Flow | -$11,742 | -$14,278 | -$20,562 | -$16,264 |
| Forex Effect | -$298 | $100 | -$32 | -$266 |
| Net Chg. in Cash | -$1,934 | $5,876 | -$4,890 | $2,749 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,393 | $7,517 | $12,407 | $9,658 |
| End Cash | $11,459 | $13,393 | $7,517 | $12,407 |
| Free Cash Flow | $13,805 | $11,705 | $11,565 | $12,100 |